Drug data last refreshed 12h ago · AI intelligence enriched 1w ago
Vasopressin is a synthetic vasopressin (antidiuretic hormone) administered intravenously as a solution. It is indicated for variceal bleeding, shock, and other critical care conditions where vasoconstrictive support is required. The drug works by binding to vasopressin receptors to increase vascular tone and blood pressure in emergency settings.
Product is in peak commercial phase with moderate competitive pressure (30%), suggesting stable team size and ongoing commercial support needs in hospital and critical care channels.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Intranasal Vasopressin Treatment in Children With Autism
The Effect of Vasopressin on Glucose Regulation
Worked on VASOPRESSIN at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on Vasopressin offers exposure to hospital-based sales, critical care relationships, and emergency medicine channels. Career growth is driven by market penetration and formulary management rather than new indication launches or clinical pipeline expansion.